Parthenolide, a Sesquiterpene Lactone, Expresses Multiple Anti-cancer and Anti-inflammatory Activities
- 21 May 2011
- journal article
- review article
- Published by Springer Science and Business Media LLC in Inflammation
- Vol. 35 (2), 560-565
- https://doi.org/10.1007/s10753-011-9346-0
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- The Feverfew plant-derived compound, parthenolide enhances platelet production and attenuates platelet activation through NF-κB inhibitionThrombosis Research, 2011
- Ex VivoActivity of Histone Deacetylase Inhibitors against Multidrug-Resistant Clinical Isolates ofPlasmodium falciparumandP. vivaxAntimicrobial Agents and Chemotherapy, 2011
- The NF (Nuclear factor)‐κB inhibitor parthenolide interacts with histone deacetylase inhibitors to induce MKK7/JNK1‐dependent apoptosis in human acute myeloid leukaemia cellsBritish Journal of Haematology, 2010
- Anti-inflammatory Compounds Parthenolide and Bay 11-7082 Are Direct Inhibitors of the InflammasomeJournal of Biological Chemistry, 2010
- The P2X7 receptor–pannexin connection to dye uptake and IL-1β releasePurinergic Signalling, 2009
- Is NF-κB a good target for cancer therapy? Hopes and pitfallsNature Reviews Drug Discovery, 2009
- 15-deoxy-Δ prostaglandin J2-induced heme oxygenase-1 in megakaryocytes regulates thrombopoiesisJournal of Thrombosis and Haemostasis, 2008
- Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilizationNature Immunology, 2008
- The Nalp3 inflammasome is essential for the development of silicosisProceedings of the National Academy of Sciences of the United States of America, 2008
- Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancerNature Reviews Cancer, 2006